ReviewGlycoconjugate journal2022
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.
Nouara Yahi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it